• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Public Health

Influenza vaccination of surgical inpatients not associated with adverse effects

byNicholas WoolfandSai Folmsbee
March 15, 2016
in Public Health, Surgery
Reading Time: 2 mins read
Needlestick injuries most common in first six months of residency
Share on FacebookShare on TwitterShare on LinkedIn

1. From a cohort study, surgical patients who were vaccinated preoperatively were not at a higher risk for inpatient visits, emergency department visits or post-discharge fever.

Evidence Rating Level: 2 (Good)

Study Rundown: According to the most recent CDC guidelines, the influenza vaccine should be administered to everyone aged 6 months or older on an annual basis. Hospital visits are an excellent time for patients to receive the vaccine as part of their care; however, providers have shown concerns that the vaccine’s side effects could be misinterpreted as post-operative complications in surgical patients. This retrospective cohort study compared the rates of outpatient, inpatient and emergency department (ED) visits in the first week after discharge between surgical patients who received the flu vaccine and those who did not receive it. Rates of post-discharge fever and infection work-up were also compared between the two groups. The findings demonstrated no significant difference in relative risk of further ED visits, readmissions, post-discharge fevers or clinical work-ups of infection between the two groups. There was a slight increase in outpatient visits during the first seven days after discharge for the vaccinated group. This study is limited in that it did not assess outcomes past seven days post-discharge, and it did not distinguish between planned and unplanned readmissions or outpatient visits. Overall, these data suggest that surgical patients who receive the flu vaccine may not be at an increased risk for further complications.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: Influenza vaccination is safe and immunogenic when administered to hospitalized patients

FDA approvedFor influenza: mFlusiva (Influenza Vaccine, mRNA), Aug 5, 2026→

In-Depth [retrospective cohort study]: Surgical inpatients of the Kaiser Permanente Southern California (KPSC) healthcare system aged 6 months or older and eligible for an influenza vaccination were included in this study. The primary outcomes included rates of outpatient, inpatient and ED visits in the first week after discharge. Rates of fever and clinical work-up for infection in the first week following discharge were also assessed. There were 42,777 surgeries included in the adjusted analyses, and the flu vaccine was administered in 6,420 (15.0%). There were no significant differences between vaccinated and unvaccinated patients in terms of inpatient visits (RR 1.12; 95%CI 0.96 to 1.32), ED visits (RR 1.07; 95%CI 0.96 to 1.20), fever (RR 1.00; 95%CI 0.76 to 1.31) or clinical work-ups for infection (RR 1.06; 95%CI 0.99 to 1.13) during the first week after discharge. A slightly increased risk of outpatient visits was observed in the vaccinated cohort (RR 1.05; CI 1.00 to 1.10; p = 0.032).

RELATED REPORTS

First messenger RNA influenza vaccine outperforms standard-dose vaccination

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Influenza vaccine
Previous Post

Abrupt smoking cessation associated with improved abstinence from smoking

Next Post

Sepsis associated with susceptibility to further infections and immunosuppression

RelatedReports

An illustration showing a vaccine vial, a protective shield, and an mRNA strand alongside influenza virus particles, symbolizing the mRNA flu vaccine.
Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

September 15, 2026
Vaccination collage: a smiling woman with a round plaster on her upper arm beside an open cool box of capped vaccine vials
Pharma

mFlusiva becomes the first mRNA influenza vaccine approved by the FDA

August 26, 2026
Pain control after surgery collage: an older woman resting on a hospital pillow beside a teal nerve that branches at one end
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Next Post

Sepsis associated with susceptibility to further infections and immunosuppression

2 Minute Medicine Rewind March 14, 2016

Noninvasive ventilation beneficial in abdominal surgery patients with hypoxemic respiratory failure

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nipocalimab patient interviews identify mouth dryness as the most important symptom to improve in phase 2 Sjögren’s disease data
  • CDC reports 5,182 confirmed measles cases in the United States in 2026
  • In selected patients with anterior-circulation large-vessel stroke 24-72 hours after onset, thrombectomy improved 90-day function but increased hemorrhage and death
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.